Health Care/Hospital
NetOP Technology: Internet-of-Things Tech Likely to Dominate in 2020s
Technologies associated with the 'Internet of Things' (IoT) are spreading rapidly, with the total number of internet-linked devices now triple the global population. According toOlcay Taysi, founder of NetOP Technology, the 2020s will likely be dominated by far-reaching advances in the field of I...
2020-12-01 07:30
2342
AGC Biologics to Expand Biopharmaceutical CDMO Capacity
Doubling the production capacity at its site in Denmark to address strong demand SEATTLE, Dec. 1, 2020 /PRNewswire/ -- AGC Biologics announced that it will increase the production capacity of itsCopenhagen facility. AGC Biologics will construct a new building on land adjacent to its currentCopenh...
2020-12-01 05:55
2331
Dunxin Financial Holdings Limited Announced the signing of Intentional Cooperation Agreement with Baite Biological Group Co., Ltd.
WUHAN, China, Nov. 30, 2020 /PRNewswire/ -- Dunxin Financial Holdings Limited ("Dunxin" or the "Company" NYSE American: DXF), a licensed microfinance lender serving individuals and small and medium enterprises (SMEs) inHubei Province, China, today announced that the Company signed an Intentional ...
2020-12-01 05:30
6241
ORTHO Optix™ Reader Now Available in CE Mark Countries, Completes Transfusion Medicine Portfolio
RARITAN, N.J., Dec. 1, 30, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the CE Mark availability of the semi-automated ORTHO Optix™ Reader, which allows lo...
2020-12-01 00:57
1448
Taiwan-based Enterprises AP Biosciences and LuminX Novel Cancer Treatments
TAIPEI, Nov. 30, 2020 /PRNewswire/ -- In recent years, an increasing number of drugs have been granted breakthrough therapy designation inthe United States, encouraging more companies to propose novel cancer treatment solutions. Currently, there are two companies inTaiwan that are accelerating th...
2020-12-01 00:00
1430
Population Council and Duchesnay Announce New International License Agreement for ANNOVERA®
NEW YORK and BLAINVILLE, QC, Nov. 30, 2020 /PRNewswire/ -- Today the Population Council and Duchesnay announce an exclusive license agreement to make ANNOVERA® (segesterone acetate and ethinyl estradiol vaginal system), the first and only contraceptive fully under a woman's control to protect aga...
2020-11-30 23:00
2745
Change Healthcare Acclaimed by Frost & Sullivan for Supporting Value-based Care with Its Enterprise Imaging Network™ Platform
SANTA CLARA, Calif., Nov. 30, 2020 /PRNewswire/ -- Based on its recent analysis of the North American cloud-based enterprise imaging market, Frost & Sullivan recognizesChange Healthcare with the 2020 North American Customer Value Leadership Award. The company helps healthcare organizations drive ...
2020-11-30 22:00
3580
United Imaging Caps Year of Expansion with Major Product Launches at RSNA
HOUSTON, Nov. 30, 2020 /PRNewswire/ -- United Imaging, a platinum sponsor at RSNA's virtual conference, announced the uCT® ATLAS, a510k pending ultra-wide bore Computed Tomography system with innovative AI technology. The announcement rounds out a year in which United Imaging reached over 10,500...
2020-11-30 22:00
1793
"Emma by AXA", the insurance and healthy living partner
HONG KONG, Nov. 30, 2020 /PRNewswire/ -- Emma by AXA --- AXA's all-in-one insurance & health services platform is now providing first-in-market free "Post-Vaccination Protection".Hong Kong and Macau residents can enjoy one year of free "Post-Vaccination Protection" by downloading the Emma by AXA ...
2020-11-30 19:35
4695
AIA Study Reveals the Ingredients to Living Healthier, Longer, Better Lives
HONG KONG, Nov. 30, 2020 /PRNewswire/ -- AIA Group Limited ("AIA" or the "Company": stock code: 1299) today released findings from a ground-breaking research initiative,"Healthier Together", revealing eight key ingredients that enable people to live "Healthier, Longer, Better Lives" – the same be...
2020-11-30 17:54
5094
Technological Advancements in Manufacturing Boost the Cell and Gene Therapy Market, Says Frost & Sullivan
CGT CDMO market is likely to reach $10.11 billion by 2026 from $1.52 billion in 2019, at a CAGR of 31% SANTA CLARA, Calif., Nov. 30, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manu...
2020-11-30 17:02
1258
GNC NMN Anti-Aging Products Make Global Debut at CIIE, Empowering the Development of China's Health and Nutrition Industry
SHANGHAI, Nov. 30, 2020 /PRNewswire/ -- With the advent of the post-COVID-19 era, the medical and healthcare industry has received unprecedented attention. At the 3rd China International Import Expo (CIIE), the much-anticipated medical device and healthcare exhibition area is also the one with th...
2020-11-30 11:00
2467
RedHill Biopharma Expands U.S.-Based Manufacturing Capacity of Opaganib for COVID-19
RedHill adds two more manufacturing partners, both U.S.-based, for large-scale manufacturing of opaganib, in preparation for potential emergency use applications as early as Q1/2021 The new collaborations follow recently announced collaborations with European and Canadian manufacturers U.S. Pha...
2020-11-30 10:45
3781
GNC NMN Anti-Aging Products Make Global Debut at CIIE, Empowering the Development of China's Health and Nutrition Industry
SHANGHAI, Nov. 29, 2020 /PRNewswire/ -- With the advent of the post-COVID-19 era, the medical and healthcare industry has received unprecedented attention. At the 3rd China International Import Expo (CIIE), the much-anticipated medical device and healthcare exhibition area is also the one with th...
2020-11-30 10:43
1936
Gilead Sciences' Pulse Survey Highlights Majority of People Living with HIV, Individuals at Risk and HIV Care Prescribers in Asia Pacific Experience Disruptions in HIV Care During COVID-19 Pandemic
HONG KONG, Nov. 30, 2020 /PRNewswire/ -- Gilead Sciences, Inc. today announced findings from a pulse survey conducted to evaluate the impact of the COVID-19 pandemic on the access and delivery of care in HIV, which includes testing, treatment and prevention, inAsia Pacific. The survey revealed ...
2020-11-30 10:40
6433
Ascentage Pharma Enters into an Agreement with University of Michigan to obtain an exclusive license for a MDM2 Degrader using PROTAC Technology
SUZHOU, China and ROCKVILLE, Md., Nov. 30, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced it has entered into an ag...
2020-11-30 08:09
2765
Gannex Appoints Former Takeda Head of Liver Disease Clinical Development Melissa Palmer, MD as Chief Medical Officer
SHANGHAI, Nov. 30, 2020 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) and fully dedicated to the R&D and commercialization of new drugs in the field of NASH, announced today that Melissa Palmer, MD, an internationally renowned Hepatologist, will join the Compa...
2020-11-30 08:00
3165
Kalkine Pty Limited To Launch its 'Australian Equity Technical Analysis Report'
SYDNEY, Nov. 30, 2020 /PRNewswire/ -- Kalkine Pty Limited is pleased to announce the launch of a new technical analysis-driven research product 'Technical Analysis Report'. This report aims to evaluate equity opportunities in consideration of sufficient risk-appetite and financial flexibility, and...
2020-11-30 06:00
2445
Varian Partners with Sony Foundation Australia in the You Can Stay Program
PALO ALTO, Calif., Nov. 30, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has entered a partnership with Sony Foundation Australia to support its You Can Stay Program. The You Can Stay program provides free accommodations for cancer patients aged between 15 to 25 and their families i...
2020-11-30 05:15
3846
Eluminex Biosciences, an Ophthalmology-Focused Biotechnology Company, Announces Closing of $50 Million Series A Financing
* Proceeds to fund development of novel and best-in-class therapeutics for eye diseases * Charles Semba, MD, joins the company to serve as Chief Medical Officer SHANGHAI, Nov. 27, 2020 /PRNewswire/ -- Eluminex Biosciences Limited (Eluminex), an ophthalmic biotechnology company committed to th...
2020-11-27 21:00
4168
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 328 media titles]
2025-01-18 03:30
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 302 media titles]
2025-01-18 17:00
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 295 media titles]
2025-01-14 21:00
URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 294 media titles]
2025-01-13 10:44
